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Abstract: The binding of harmane with human serum albumin (HSA) and 
bovine serum albumin (BSA) were studied by fluorescence and 
phosphorescence spectroscopic methods. Quenching of fluorescence of 
serum albumins by harmane was found to be a static quenching process. 
The equilibrium constant (K) of complex formation was found to be equal 
to (5.16±0.28)x104 M-1 and (4.32±0.30)x104 M-1 for HSA and BSA, 
respectively. It was found that the interactions of harmane with HSA and 
BSA were also in the excited triplet state. The determined bimolecular 
constant or triplet state quenching (kqT)of the proteins studied by harmane 
was (1.15± 0.10)x107 M-1 s-1 and (2.88±0.22)x107 M-1 s-1 for HSA and BSA, 
respectively. Based on the similar value of K and kqT for HSA and BSA, a 
possible suggestion is that, most probably, the binding site of 
harmane is located in the drug site 1 in the subdomain IIa. 
Keywords: human and bovine serum albumin, harmane, fluorescence, 
phosphorescence. 
Introduction 
Harmane (1-methyl-β-carboline) (Figure 1) is one of the derivatives of 
alkaloids which are produced naturally by plants. It has been found in alcoholic 
beverages, well-cooked foods and tobacco smoke. According to previous 
researches, β-carboline has been reported as a normal constituent of human 
tissues and body fluids [1]. Also β-carboline affects a variety of biochemical, 
psychopharmacological, and behaviors in animals and humans [2]. 
The applications of alkaloids involve in biological control of herbivores; they 
also have pharmacological veterinary and medical interest [3]. For instance, 
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a wide range of pharmacological properties including antimicrobial [4], anti-HIV 
[5] and antiparasitic properties [6,7] have been found in some alkaloids 
belonging to the β-carboline group. Harmane has some biochemical action  
including inhibition of monoamine oxidase [8] and cytochrome P-450 [9], and 
binding to benzodiazepine [10] and serotonin receptors [11]. Funayama et al. 
[12] demonstrated that the relaxation activity of DNA topoisomerase I and II is 
inhibited by this compound. 
For instance, harmane binds with high affinity to benzodiazepine receptors 
and tryptamine sites in the brain of rats [13] and will evoke an anxiety-like state 
[14] which is attenuated by a benzodiazepine [15]. Furthermore, harmane is a  
monoamine-oxidase (MAO) inhibitor (inhibitor of MAO-A and MAO-B, 
respectively) which acts to modify the addictive effects of nicotine and effects on 
motor activity. Harmane binds with several bio-molecules such as serum 
albumins. 
Serum albumins are proteins located within the plasma and, are present in vast 
quantities [16]. These proteins have numerous functions including carrier 
proteins, maintenance of pH and regulation of osmotic pressure within the extra-
vascular fluids [17]. Serum albumins contain three homologous helical domains 
(I–III), each divided into A and B subdomains. The chemical structures of human 
serum albumin (HSA) and bovine serum albumin (BSA) are very similar, they 
share 76% homology [18], and both contain tryptophanyl residues (Trp). BSA 
has two of these residues; Trp 134 and Trp 213, whereas HSA contains only one; 
Trp 214 [19]. Serum albumins can bind to a large number of substances including 
endogenous and exogenous molecules thus the binding of drugs is of key interest 
[17]. In HSA and BSA structure two binding sites of drugs (1 and 2), located in 
subdomains IIA and IIIA, respectively can be distinguished. Both the drug 
binding sites are topologically similar but they differ in shape, size and polarity. 
Tryptophanyl residues Trp 213 and Trp 214 in HSA and BSA, respectively are 
located in the site 1 [20, 21]. 
Until now the interactions between harmane and serum albumins were 
analyzed by the use of UV-Vis and FTIR spectroscopy. Recent studies suggest 
that BSA can be considered a good carrier for transportation of β-carboline 
alkaloids [22]. 
The aim of this work is to study the interactions between harmane and serum 
albumins by the use of fluorescence and phosphorescence spectroscopy. This 
should give information about the mechanism in the ground and excited state 
interaction. A precise knowledge of drug-biomolecular interactions is crucial for 
a rational design of pharmaceuticals [17]. 
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Figure 1. Structure of harmane 
Experimental 
Materials 
Harmane, BSA, HSA, potassium iodide and sodium sulphite used in this study 
were commercial products of Sigma-Aldrich and were used as received. All 
chemicals were dissolved in 0.05 M phosphate buffer (pH = 7.0). Also high-
purity water from Milli-Q system was used in the performed.  
Methods 
Steady-state fluorescence measurements were made using spectrofluoremeter 
Fluoromax-4 (3000 signals/noise) from Jobnon Yvon-spex. Fluorescence lifetime 
measurements were carried out with a FL900CDT time-correlated single photon 
counting fluorimeter from Edinburgh Analytical Instruments. Solutions were 
placed into a 10 mm quartz cuvette which were kept at room temperature. 
Phosphorescence measurements were made on a homemade system. The heart of 
this system consists of 800 MHz gated photon counters with 32 bit counters and 
down to 250 ns per channel (PMS-400A, Becker&Hickl GmbH). Emission was 
excited by UV xenon flash lamp with 400 ns pulses, pulse energy 7.8 μJ, light output 
stability 1.9% p-p and repetition rate up to 100 Hz. The system was calibrated on an 
aqueous solution of TbCl3. The lifetime was 426.5 microseconds and consistent with 
literature data (427 microseconds). O2 removal was achieved by the application of a 
moderate vacuum and inlet of ultrapure nitrogen. The pre-purified nitrogen gas (0.1 
ppm of O2) was further purified by passing through an oxygen-trapping filter. This 
degassing procedure was further accompanied by the addition of 0.3 ml of 0.1 M 
Na2SO3 as an O2 scavenger [23]. The sample was placed in a quartz cuvette, which 
was connected to the N2/vacuum line by tubing. Five cycles of deoxygenation were 
performed. After deoxygenation, the cuvette was moved into the phosphorimeter. 
Time-resolved fluorescence and phosphorescence data results were analyzed 
according to the multi-exponential decay law: 
  n ii 1
i
tI t exp                                                                                          (eq 1) 
where αi and τi are preexponential factor and decay lifetime of component i, 
respectively. 
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Results and ?iscussion 
Steady-state fluorescence measurements 
Useful information can be provided by fluorescence measurements about the 
molecular environment in the region of the fluorophore. The effect of harmane 
on the fluorescence emission spectrum of HSA and BSA, excited at 290 nm are 
presented in Figure 2.  
The emission spectrum showed two maxima, the first one at about 345 nm 
(which is characteristic for tryptophan in serum albumins) and the second peak 
with very high fluorescence intensity at about 430 nm (which can be assigned to 
harmane). 
 
 
Figure 2. Emission spectra of (A) HSA and (B) BSA in the presence of various 
concentrations of harmane. The characteristic emission region for 
HSA and BSA, are presented in fig A’ and B’, respectively. The total 
concentration of proteins was 3 μM. The wavelength excitation was 
290 nm 
Fluorescence quenching can be related to any process which reduces the 
fluorescence intensity of a given sample. There are two main types of quenching 
that can describe the mechanism of the binding between quencher and 
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macromolecules: static and dynamic (which is also known as collision 
quenching) [24]. The mechanism of harmane binding to HSA and BSA is 
described using the Stern-Volmer equation: 
     0 q 00 iF 1 K Q 1 k QF                                                                           (eq 2) 
where F0 and F are the fluorescence intensities in the absence and the presence of 
the quencher, respectively, K is the equilibrium constant for complex formation 
in ground state, in the presence of quencher; [Q]0 is the analytical concentration 
of the quencher; kq is the rate constant for quenching; τ0 is the fluorescence 
lifetime of the chromophore in the absence of quencher; [Q]i is the concentration 
of a free quencher. The first bracket describes static quenching and the second 
describes dynamic quenching. The Stern-Volmer plot of the studied molecules 
are presented in Figure 3. 
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Figure 3. The Stern-Volmer plots for harmane quenching of the proteins studied 
at room temperature. The concentration of proteins was 3 μM. The 
wavelength excitation was 290 nm and the wavelength emission was 
340 nm 
The straight line obtained in the Stern-Volmer plot suggests the presence of 
either purely static or dynamic quenching, but identification of one unequivocal 
quenching mechanism at this stage is not possible. 
Time-resolved fluorescence measurements 
Therefore, time resolved fluorescence spectroscopy was used to determine the 
decay times, thus enabling the differentiation between the presence of static and 
dynamic quenching. The kinetics of the fluorescence decay of the molecules 
studied are presented in Figure 4 and the decay parameters are listed in Table 1. 
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Figure 4. The kinetics of the fluorescence decay of (A) HSA and (B) BSA in 
the absence and presence of harmane. The total concentration of 
proteins was 3 μM. The wavelength excitation was 295 nm and the 
wavelength emission was 345 nm 
 
Table 1. Parameters of the fluorescence decay fits, using the eq 1 
 Charmane [μM] τ1 [ns] τ2 [ns] τav [ns] 
HSA 
0 2.23±0.04 6.80±0.03 5.90±0.05 
3.3 2.25±0.04 6.77±0.03 5.85±0.05 
10 2.26±0.04 6.76±0.03 5.84±0.04 
17 2.28±0.04 6.76±0.03 5.83±0.04 
BSA 
0 3.01±0.23 6.69±0.04 6.44±0.08 
3.3 2.98±0.19 6.62±0.04 6.39±0.07 
10 2.96±0.15 6.60±0.04 6.35±0.06 
17 2.92±0.13 6.59±0.03 6.34±0.08 
Despite the addition of harmane, the τav values for HSA and BSA have not 
been changed within the experimental error limits. This indicated that there is no 
interactions between the studied proteins and harmane in the excited state and 
suggest that there is only static quenching. Therefore, the slope in Figure 3 may 
be considered as the equilibrium constant for complex formation in the ground 
state with values (5.16±0.28)x104 M-1 and (4.32±0.30)x104 M-1 for HSA and 
BSA, respectively. The determined value for BSA is not consistent with the 
values obtained by Nafisi et al. (1.41x103 M-1) [22]. 
Phosphorescence measurements 
Phosphorescence can provide useful information about the nature of the 
interactions between the proteins and the quencher and its affect on the lifetime 
of the triplet state, because it observed drastic dependence of the tryptophan 
phosphorescence lifetime on the differences in the rigidity of the indole 
environment [25]. As shown in Figure 5, the maximum of phosphorescence 
emission was 460 nm and 450 nm for HSA and BSA, respectively and this values 
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are typical for tryptophan in protein. The phosphorescence signal for harmane 
was not registered in the region of 480-600 nm. 
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Figure 5. Phosphorescence spectra for HSA and BSA. The concentration of 
proteins was 30 μM. The wavelength excitation was 290 nm 
We observed a decrease in phosphorescence lifetime with an increased 
concentration of harmane. The bimolecular constant rate for quenching of the 
triplet states Tqk  was calculated using the following equation: 
T
q0
ph ph
1 1 k [Q]                                                              (eq 3) 
where 0ph  is the phosphorescence lifetime in the absence of quencher; [Q] is the 
concentration of harmane. A plot of 1/τph vs [Q] should yield a straight line with 
an intercept of 1/τph and a slope equal to the bimolecular triplet state quenching 
rate constant Tqk  (Figure 6). 
 
Figure 6. Harmane quenching of the triplet state of HSA (A) and BSA (B). 
Concentration of the studied protein and KI was 30 μM and 0.2 M, 
respectively. The wavelength excitation was 290 nm and the emission 
was observed with the filter 440-460 nm 
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The determined bimolecular constant for triplet state quenching of the 
proteins studied by harmane was (1.15±0.10)x107 M-1 s-1 and (2.88±0.22)x107  
M-1s-1 for HSA and BSA, respectively. The phosphorescence lifetime in the 
absence of the quencher was calculated to be 0.472 ms for HSA and 0.252 ms for 
BSA. Potassium iodide (KI, heavy atom) was used to enhance intersystem 
crossing by ensuring that the triplet state will be the major pathway of tryptophan 
S1 decay. The concentration of KI was kept constant so it did not affect the 
phosphorescence lifetime. 
Conclusions 
The aim of this research was to study the interactions between the serum 
albumins and harmane by the use of fluorescence and phosphorescence 
spectroscopy. The fluorescence measurements revealed that harmane quenched 
fluorescence of tryptophan in HSA and BSA and, most probably, the mechanism 
involved is static quenching. Also the interactions between the studied 
compounds have been observed in the excited triplet state. The decrease in both 
the fluorescence and phosphorescence intensity and similar value of the 
equilibrium constant for complex formation in ground state for HSA and BSA 
indicate that, most probably, the binding site of harmane is located in the drug 
site 1 in the subdomain IIa. This study suggests that albumin, as a drug carrier, 
plays an important role in the pharmacological effects of harmane and gives us 
further insight into the pharmacokinetics. 
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